Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma

[1]  W. Pei,et al.  The safety and prognosis of radical surgery in colorectal cancer patients over 80 years old , 2023, BMC Surgery.

[2]  V. Longo,et al.  Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review , 2023, Journal of clinical medicine.

[3]  J. Li,et al.  Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma , 2023, Current oncology.

[4]  G. Umana,et al.  Intramedullary Spinal Cord Metastases from Breast Cancer: A Systematic Review , 2023, AntiCancer Research.

[5]  I. Menjak,et al.  Immunotherapy for older patients with cancer. , 2023, Current opinion in supportive and palliative care.

[6]  L. Goodridge,et al.  Inhibition of Cronobacter sakazakii in an infant simulator of the human intestinal microbial ecosystem using a potential synbiotic , 2022, Frontiers in Microbiology.

[7]  Jing Neng,et al.  Ferulic acid improves intestinal barrier function through altering gut microbiota composition in high-fat diet-induced mice , 2022, European Journal of Nutrition.

[8]  Chaofan Liu,et al.  Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota , 2022, Aging.

[9]  H. Tilg,et al.  Gut microbiome and health: mechanistic insights , 2022, Gut.

[10]  Tongze Fu,et al.  Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure , 2022, Frontiers in Microbiology.

[11]  Bo Chen,et al.  Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer , 2022, Hepatology International.

[12]  N. Lyu,et al.  Immunotherapy in older patients with hepatocellular carcinoma. , 2021, European journal of cancer.

[13]  Baohong Wang,et al.  The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration , 2021, Frontiers in Immunology.

[14]  Biao Xu,et al.  Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: A pilot study. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[15]  F. Gómez-Chávez,et al.  Microbiota Signals during the Neonatal Period Forge Life-Long Immune Responses , 2021, International journal of molecular sciences.

[16]  R. Nasr,et al.  Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome , 2021, International journal of molecular sciences.

[17]  Dan Li,et al.  Gut microbiota changes and its potential relations with thyroid carcinoma. , 2021, Journal of advanced research.

[18]  Tianyou Chen,et al.  Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study , 2021, Bioengineered.

[19]  Hongwei Li,et al.  Gut Microbiotic Features Aiding the Diagnosis of Acute Ischemic Stroke , 2020, Frontiers in Cellular and Infection Microbiology.

[20]  Hang Zhou,et al.  The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma , 2020, European journal of gastroenterology & hepatology.

[21]  J. Yun,et al.  Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) , 2020, Liver Cancer.

[22]  E. Tartour,et al.  Immunotherapy in older patients with cancer , 2020, Biomedical journal.

[23]  Longfei Lin,et al.  The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017 , 2020, Liver Cancer.

[24]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[25]  Hongwei Li,et al.  Altered diversity and composition of gut microbiota in Wilson's disease , 2020, Scientific Reports.

[26]  R. Schwabe,et al.  Gut microbiome in HCC - Mechanisms, diagnosis and therapy. , 2020, Journal of hepatology.

[27]  J. Lundgren,et al.  Impact of Hiv-Related Gut Microbiota Alterations on Metabolic Comorbidities. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Hongwei Li,et al.  Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer , 2019, International journal of biological sciences.

[29]  Guangxiu Liu,et al.  Relationship between intestinal microbial dysbiosis and primary liver cancer. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[30]  Yewei Zhang,et al.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.

[31]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[32]  Lanjuan Li,et al.  Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma , 2018, Gut.

[33]  A. Gasbarrini,et al.  Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease , 2018, Hepatology.

[34]  Alvaro G. Hernandez,et al.  Bile acid oxidation by Eggerthella lenta strains C592 and DSM 2243T , 2018, Gut microbes.

[35]  R. Schwabe,et al.  The gut microbiome and liver cancer: mechanisms and clinical translation , 2017, Nature Reviews Gastroenterology &Hepatology.

[36]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[37]  Yunfeng Li,et al.  Dysbiosis of Intestinal Microbiota Associated With Inflammation Involved in the Progression of Acute Pancreatitis , 2015, Pancreas.

[38]  B. Chassaing,et al.  Microbiota‐liver axis in hepatic disease , 2014, Hepatology.

[39]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[40]  Tsung-Han Hsieh,et al.  Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC , 2013, BMC Genomics.

[41]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[42]  J. Faivre,et al.  Targeting gut flora to prevent progression of hepatocellular carcinoma. , 2013, Journal of hepatology.

[43]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[44]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[45]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[46]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[47]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..

[48]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[49]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[50]  Chien-Jen Chen,et al.  Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[51]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[52]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[53]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[54]  Mechanistic insights , 2022 .